Annual Report

Overview

The report covers FY2018, when the JCR Group achieved consolidated net sales of 23,160 million yen and launched Agalsidase Beta BS I.V. Infusion [JCR], its first domestically produced ERT for LSDs. It describes sustainability work across rare diseases, society, environment, and corporate governance, including 6,420 tons of CO2 emissions and 44,049 m3 of water use. The company also reported 632 consolidated employees at March 31, 2019.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2018-2019
Period: 1 April 2018 – 31 March 2019
Language: English
Pages
File size

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services